Target intelligence / Profile preview

Phagocytic immune cells in lymph nodes

Molecular classification
Other
01

Overview

Phagocytic immune cells in lymph nodes, primarily consisting of various macrophage subsets (such as subcapsular sinus and medullary macrophages) and dendritic cells, serve as the primary filtration and surveillance system of the lymphatic network. These cells are responsible for capturing lymph-borne antigens, pathogens, and debris, subsequently processing and presenting them to T and B lymphocytes to initiate adaptive immune responses (StatPearls, 2023). While they are critical for host defense and are frequently the focus of drug delivery strategies (e.g., nanoparticle-based vaccines or imaging agents), they do not represent a single molecular target but rather a heterogeneous population of cells with diverse functional roles. In the context of oncology, these cells can either promote anti-tumor immunity or be subverted into a pro-tumorigenic, immunosuppressive state that facilitates metastasis (Nature Reviews Immunology, 2019). Because the term describes a cellular anatomical location rather than a specific protein, enzyme, or receptor, it is considered a 'target population' in pharmacology rather than a canonical molecular target.

Other names
Lymph node macrophagesSubcapsular sinus macrophagesMedullary macrophagesLymph node dendritic cellsAntigen-presenting cells in lymph nodes
02

Mechanism of action

Not applicable as this is a cell population, not a single molecular target.

03

Biological functions

Immune responseAntigen processing and presentationPhagocytosisLymphatic filtrationCytokine production
04

Disease associations

CancerInfectionAutoimmune diseaseInflammation
05

Safety considerations

Off-target immune activationSystemic inflammationImpaired lymphatic clearanceAutoimmunity
06

Biomarkers

CD169 (Sialoadhesin)CD11bCD68F4/80CD11c

Beyond the preview

Go deeper on Phagocytic immune cells in lymph nodes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phagocytic immune cells in lymph nodes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call